ANI Pharmaceuticals Inc
Suletud
SektorTervishoid
82.22 -0.36
Ülevaade
Aktsiahinna muutus
24h
Min
82.04
Max
83.9
Sissetulek | -61K 27M |
|---|---|
Müük | -9.6M 237M |
P/E Sektori keskmine | 20.609 50.958 |
Aktsiakasum | 1.68 |
Kasumimarginaal | 11.551 |
Töötajad | 970 |
EBITDA | -20M 57M |
Soovitused | Tugev "osta" hinnang |
|---|---|
12 kuu keskmine prognoos | +37.81% upside |
Järgmine tulemuste avaldamine | 7. aug 2026 |
|---|
Turukapital | -41M 1.8B |
|---|---|
Eelmine avamishind | 82.58 |
Eelmine sulgemishind | 82.22 |
Uudiste sentiment
By Acuity
50%
50%
146 / 342 Pingereas Healthcare
ANI Pharmaceuticals Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Ettevõttest ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.